What is it about?
Hepatocellular carcinoma in non-fibrotic liver.
Featured Image
Why is it important?
Hepatocellular carcinoma (HCC) in a non-fibrotic liver (F0) is considered to be rare, and there is a marked paucity of studies in the literature on this HCC type. A review of the literature shows some important clinical and tumor characteristics: (a) it occurs mainly in young female and elder male patients; (b) clinically, under normal hepatic function, alpha-fetoprotein level is often normal, and there are no risk factors; (c) associated with metabolic disease; (d) macroscopically, single large lesions are noted; and (e) microscopically, the lesions are well-differentiated and encapsulated. Radiological imaging results are straightforward, showing arterial hyperenhancement and later wash-out. The combined use of B-mode and contrast-enhanced (CE) ultrasound (US) is the most reliable and cost-effective diagnostic method. Few peri-and post-operative complications are noted and 5-year survival is not inferior to patients with HCC on fibrosis liver despite the lesion’s large size.
Perspectives
Read the Original
This page is a summary of: Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review, Diagnostics, November 2023, MDPI AG,
DOI: 10.3390/diagnostics13223426.
You can read the full text:
Contributors
The following have contributed to this page